EMEA-001262-PIP01-12-M03

Key facts

Active substance
Dobutamine
Therapeutic area
Cardiovascular diseases
Decision number
P/0182/2017
PIP number
EMEA-001262-PIP01-12-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of neonatal circulatory failure
Route(s) of administration
Intravenous use
Contact for public enquiries
Proveca Limited

Tel. +44 7913048665
E-mail: simon@proveca.co.uk

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating